CAS: 16806-93-2; 6,7-Dihydrobenzofuran-4(5H)-One

相似化合物

157435-90-0 84099-58-1 50615-16-2

上下游产品

CAS号107-20-0 一氯乙醛 | CAS号504-02-9 1,3-环己二酮 | CAS号183495-78-5 2-phenylsulfany... | CAS号150-78-7 对苯二甲醚 | CAS号66144-45-4 4-(furan-2-yl)b... | CAS号35768-38-8 3-hydroxy-3,5,6... | CAS号1460-08-8 2-diazonio-3-ox... | CAS号108-05-4 乙酸乙烯酯 | CAS号2032-35-1 2-溴-1,1-二乙氧基乙烷 | CAS号480-97-7 苯并呋喃-4-醇 | CAS号51471-08-0 1,5,6,7-四氢-1-甲基... | CAS号192061-80-6 1-(2-hydroxyeth... | CAS号13618-91-2 4,5,6,7-四氢吲哚 | CAS号13754-86-4 1,5,6,7-四氢-4H-吲哚-4-酮 | CAS号13671-74-4 1-benzyl-6,7-di... | CAS号81565-17-5 1-prop-2-enyl-6... | CAS号84099-58-1 4,5,6,7-四氢苯并呋喃-4-醇 | CAS号94123-39-4 11-methyl-4,5-d... | CAS号61190-48-5 5,6,7,8-TETRAHY...

氯乙醛置于氢氧化钾体系中,用 甲醇,水 用作溶剂,化学反应 0.5H,以63.5%的收率获得6,7-二氢-4(5H)-苯并呋喃酮
参考文献:3-Phenoxy-4-Pyridazinol Derivative And Herbicide Composition Containing The Same
标题:3-Phenoxy-4-Pyridazinol Derivative And Herbicide Composition Containing The Same

专利信息

专利号:US-2007197797-A1
优先权日:2005-12-30
标 题 :Compounds and methods for carbazole synthesis
发明人：HARRINGTON PETER J
权利人:HARRINGTON PETER J
摘要:Compounds having bi-cyclic structure comprising a partially unsaturated 6-carbon first cyclic moiety interconnected to a 6-carbon second cyclic moiety second via a divalent linking moiety are provided. The compounds can be used as intermediates compounds in methods for the synthesis of carbazoles and derviatives thereof, including carvedilol, and tricyclic alkylhydroxamates, which do not require Fischer indole synthetic steps. Methods of preparing the compounds having bi-cyclic structures are also provided.

专利号:US-7179918-B2
优先权日:2001-06-11
标 题:HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis
发明人：CANAN KOCH STACIE S; ALEXANDER THERESE N; BURKE BENJAMIN J; JEWELL TANYA M; KUCERA DAVID J; LINTON MARIA ANGELICA; MITCHELL JR LENNERT J; REICH SIEGFRIED H; SKALITZKY DONALD J; TATLOCK JOHN H; VARNEY MICHAEL D; VIRGIL SCOTT C; WEBBER STEPHEN E; WORLAND STEPHEN T; BARVIAN MARK; BOLTON GARY; BOYER JR FREDERICK EARL; MACHAK JEFFREY J; HOLLER TOD; MURPHY SEAN T; MELNICK MICHAEL; JOSYULA VARA PRASAD
权利人:AGOURON PHARMA
摘要:Compounds of the formula: n nwhere the formula variables are as defined herein, are disclosed that advantageously inhibit or block the biological activity of the HIV protease. These compounds, as well as pharmaceutical compositions containing these compounds, are useful for treating patients or hosts infected with the HIV virus. Intermediates and synthetic methods for preparing such compounds are also described.

专利号:US-4558143-A
优先权日:1982-08-06
标 题 :Process for preparing 4-oxo-4,5,6,7-tetrahydrobenzofuran
发明人：MATSUMOTO MASAKATSU; WATANABE NOBUKO
权利人:SAGAMI CHEM RES
摘要:A 4-oxo-4,5,6,7-tetrahydrobenzofuran derivative is prepared by reacting a 1,3-cyclohexanedione derivative with chloroacetaldehyde in the presence of a base while maintaining the reaction mixture at a pH of from 4 to 10, and treating the reaction mixture with an acid. The 4-oxo-4,5,6,7-tetrahydrobenzofuran derivatives are useful as an intermediate for synthesis of various kinds of drugs.

专利号:TW-509675-B
优先权日:1997-11-13
标 题 :Method of synthesis of pyrrole amides

专利号:US-7169932-B2
优先权日:2001-06-11
标题:HIV protease inhibitors, compositions containing the same, their pharmaceutical uses, material for their synthesis
发明人：KUCERA DAVID JOHN; SCOTT ROBERT WILLIAM
权利人:PFIZER
摘要:Compounds of the formula: n nwhere the formula variables are as defined herein, are disclosed that advantageously inhibit or block the biological activity of the HIV protease. These compounds, as well as pharmaceutical compositions containing these compounds, are useful for treating patients or hosts infected with the HIV virus. Intermediates and synthetic methods for preparing such compounds are also described.

专利号:US-7094909-B2
优先权日:2001-06-11
标 题 :HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis
发明人：KUCERA DAVID JOHN; SCOTT ROBERT WILLIAM
权利人:AGOURON PHARMA
摘要:The present invention concerns processes for preparing compounds of formula (I-H), or a prodrug, pharmaceutically active metabolite, or pharmaceutically active salt or solvate thereof, n nwhich are useful as inhibitors of the HIV protease enzyme.